The Relationship Between Clotting Factor VIII and Bleeding Adverse Reactions in Patients Under the Therapies of Thrombolysis, Anticoagulation and Anti-platelet


Phase N/A Results N/A

Trial Description

The purpose of this study is to determine whether Plasma Factor VIII Levels are related to the treatment of bleeding in ischemic stroke(IS).

Detailed Description

Clear cerebral infarction patients during hospitalization, treatment process, discharge and hemorrhage occurs, the stages F VIII level change and its correlation with bleeding adverse reactions. Analysis F VIII whether belong to hemorrhage occurs independent risk factors of adverse drug reactions,as well as the feasibility of predicting bleeding occurred adverse reaction index.


Trial Design

  • Observation: Cohort
  • Perspective: Prospective
  • Sampling: Probability Sample

Trial Population

The stroke patient using Anti-thrombotic drugs diagnosed by Zhujiang Hospital.


Type Measure Time Frame Safety Issue
Primary The level of FVIII one year No
Primary The levels of FVIII are measured by enzyme-linked immuno sorbent assay. one year No